Exelixis Inc (EXEL)
36.39 -0.53 (-1.44%) 04/01/25 [NASDAQ]
35.49 x 100 38.14 x 100
Realtime by (Cboe BZX)
35.49 x 100 38.14 x 100
Realtime - - (-) -
for Tue, Apr 1st, 2025
Results
download Want to compare other data? Select Fields| Symbol | EXEL | MRNA | ASND | ||
| Company | Exelixis Inc | Moderna Inc | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.78 | 28.70 | 156.73 | ||
| High | 37.18 | 28.85 | 158.45 | ||
| Low | 35.67 | 27.07 | 148.40 | ||
| Last | 36.39 | 27.16 | 151.43 | ||
| Change | -0.53 | -1.19 | -4.43 | ||
| % Change | -1.44% | -4.20% | -2.84% | ||
| Volume | 2,799,700 | 11,640,000 | 656,200 | ||
| 20-Day Average Volume | 2,738,220 | 10,128,665 | 446,830 | ||
| Previous Close | 36.92 | 28.35 | 155.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.30 | 33.20 | 156.43 | ||
| 20-Day Raw Stochastic | 18.39% | 3.16% | 45.30% | ||
| 20-Day Relative Strength | 49.46% | 36.01% | 50.23% | ||
| Weighted Alpha | +54.79 | -75.40 | +2.21 | ||
| Today's Opinion | 88% Buy | 100% Sell | 88% Buy | ||
| Previous Opinion | 88% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.50% since 03/25/25 | -19.76% since 03/25/25 | -5.97% since 03/25/25 | ||
| Low | 35.57 on 03/31/25 | 26.80 on 03/31/25 | 143.81 on 03/31/25 | ||
| High | 38.41 on 03/26/25 | 34.08 on 03/26/25 | 161.91 on 03/27/25 | ||
| 1-Month | |||||
| %Chg | -5.94% since 02/28/25 | -12.27% since 02/28/25 | -3.29% since 02/28/25 | ||
| Low | 35.57 on 03/31/25 | 26.80 on 03/31/25 | 136.57 on 03/11/25 | ||
| High | 40.02 on 03/10/25 | 38.12 on 03/13/25 | 169.37 on 03/17/25 | ||
| 3-Month | |||||
| %Chg | +9.28% since 12/31/24 | -34.68% since 12/31/24 | +9.99% since 12/31/24 | ||
| Low | 31.90 on 01/24/25 | 26.80 on 03/31/25 | 118.03 on 02/12/25 | ||
| High | 40.02 on 03/10/25 | 48.92 on 01/07/25 | 169.37 on 03/17/25 | ||
| 6-Month | |||||
| %Chg | +38.37% since 10/01/24 | -57.52% since 10/01/24 | +3.29% since 10/01/24 | ||
| Low | 25.17 on 10/10/24 | 26.80 on 03/31/25 | 118.03 on 02/12/25 | ||
| High | 40.02 on 03/10/25 | 63.69 on 10/02/24 | 169.37 on 03/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,184,870 | 10,500,680 | 9,190,134 | ||
| Shares Outstanding, K | 279,881 | 386,623 | 60,689 | ||
| Annual Sales | 2,168,700,000 | 3,236,000,000 | 393,500,000 | ||
| Annual Net Income | 521,270,000 | -3,561,000,000 | -409,120,000 | ||
| Last Quarter Sales | 566,750,000 | 966,000,000 | 187,020,000 | ||
| Last Quarter Net Income | 139,860,000 | -1,120,000,000 | -39,990,000 | ||
| 60-Month Beta | 0.57 | 2.23 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.55 on 02/11/25 | -2.50 on 02/14/25 | -0.68 on 02/12/25 | ||
| Latest Earnings Date | 04/29/25 | 05/01/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 21.10 | 0.00 | 0.00 | ||